Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 Jun;17(6):469-76.
doi: 10.1046/j.1525-1497.2002.11111.x.

Determination of the clinical importance of study results

Malcolm Man-Son-Hing  1 , Andreas Laupacis, Keith O'Rourke, Frank J Molnar, Jeffery Mahon, Karen B Y Chan, George Wells
Affiliations
Review

Determination of the clinical importance of study results

Malcolm Man-Son-Hing et al. J Gen Intern Med. 2002 Jun.

Abstract

Formal statistical methods for analyzing clinical trial data are widely accepted by the medical community. Unfortunately, the interpretation and reporting of trial results from the perspective of clinical importance has not received similar emphasis. This imbalance promotes the historical tendency to consider clinical trial results that are statistically significant as also clinically important, and conversely, those with statistically insignificant results as being clinically unimportant. In this paper, we review the present state of knowledge in the determination of the clinical importance of study results. This work also provides a simple, systematic method for determining the clinical importance of study results. It uses the relationship between the point estimate of the treatment effect (with its associated confidence interval) and the estimate of the smallest treatment effect that would lead to a change in a patient's management. The possible benefits of this approach include enabling clinicians to more easily interpret the results of clinical trials from a clinical perspective, and promoting a more rational approach to the design of prospective clinical trials.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Possible combinations for the relationship between clinical importance and statistical significance (see text for the details).
See this image and copyright information in PMC

References

    1. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407–15. - PubMed
    1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med. 1994;154:1449–57. - PubMed
    1. EAFT (European Atrial Fibrillation Study) Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet. 1993;342:1255–62. - PubMed
    1. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest. 2001;119:194S–206S. - PubMed
    1. Gage BF, Waterman AD, Shannon W, Boechler M, Rich M, Radford MJ. Validation of clinical classification schemes for predicting stroke. JAMA. 2001;285:2864–70. - PubMed

MeSH terms